FDA Inspection
LGM Pharma, LLCLGM Pharma, LLC – FDA Inspection, Apr 14, 2022
Record Details
This FDA Inspection record concerns LGM Pharma, LLC, with an inspection on April 14, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- LGM Pharma, LLC
- Inspection Date
- April 14, 2022
- Product Type
- Drugs
View Company Profile
ID · c693db10-084d-47bd-b14b-26e398eecb24
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1167329
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.